{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:37:18Z","timestamp":1791405438592,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.vaccine.2011.07.059","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T04:51:10Z","timestamp":1312260670000},"page":"6866-6873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague"],"prefix":"10.1016","volume":"29","author":[{"given":"Yinon","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Flashner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Tidhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayelet","family":"Zauberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Aftalion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avigdor","family":"Shafferman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuelle","family":"Mamroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.07.059_bib0005","series-title":"Plague and other Yersian infections","author":"Butler","year":"1983"},{"issue":"May (17)","key":"10.1016\/j.vaccine.2011.07.059_bib0010","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"issue":"September (10)","key":"10.1016\/j.vaccine.2011.07.059_bib0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multidrug resistance in Yersinia pestis mediated by a transferable plasmid","volume":"337","author":"Galimand","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0020","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.07.059_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.07.059_bib0030","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.70.3.1453-1460.2002","article-title":"Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis","volume":"70","author":"Du","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0035","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1128\/jb.177.9.2530-2542.1995","article-title":"Differential effects of deletions in lcrV on secretion of V-antigen, regulation of the low-Ca++ response and virulence of Yersinia pestis","volume":"177","author":"Skrzypek","year":"1995","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0040","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/IAI.67.10.5395-5408.1999","article-title":"Virulence role of Vantigen of Yersinia pestis at the bacterial surface","volume":"67","author":"Fields","year":"1999","journal-title":"Infect Immun"},{"issue":"October (5748)","key":"10.1016\/j.vaccine.2011.07.059_bib0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1118476","article-title":"The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles","volume":"310","author":"Mueller","year":"2005","journal-title":"Science"},{"issue":"April","key":"10.1016\/j.vaccine.2011.07.059_bib0050","article-title":"The search for early markers of plague: evidence for accumulation of soluble Yersinia pestis LcrV in bubonic and pneumonic mouse models of disease","author":"Flashner","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2011.07.059_bib0055","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0264-410X(00)00108-0","article-title":"Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains","volume":"19","author":"Jones","year":"2001","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.07.059_bib0065","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/iai.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"Andrews","year":"1996","journal-title":"Infect Immun"},{"issue":"January (6)","key":"10.1016\/j.vaccine.2011.07.059_bib0070","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.vaccine.2006.09.052","article-title":"Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague","volume":"25","author":"Williamson","year":"2007","journal-title":"Vaccine"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2011.07.059_bib0075","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"Suppl. I","key":"10.1016\/j.vaccine.2011.07.059_bib0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1475-2859-5-S1-P98","article-title":"Production and purification of high molecular weight oligomers of Yersinia pestis F1 capsular antigen released by high cell density culture of recombinant Escherichia coli cells carrying the caf1 operon","volume":"5","author":"Holzman","year":"2006","journal-title":"Microbial Cell Factories"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.07.059_bib0085","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/iai.63.8.2854-2858.1995","article-title":"Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-1656(99)00185-6","article-title":"Endotoxin removal from protein solutions","volume":"76","author":"Petsch","year":"2000","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0095","series-title":"Combined caf1 and lcrV genetic immunization can provide protection against very high challenge dose of Y. pestis","author":"Flashner","year":"2006"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2011.07.059_bib0100","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.vaccine.2008.01.033","article-title":"Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague","volume":"26","author":"Zauberman","year":"2008","journal-title":"Vaccine"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.07.059_bib0105","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1086\/520547","article-title":"Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague","volume":"196","author":"Heine","year":"2007","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2011.07.059_bib0110","doi-asserted-by":"crossref","first-page":"e7023","DOI":"10.1371\/journal.pone.0007023","article-title":"The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague","volume":"4","author":"Tidhar","year":"2009","journal-title":"PLoS One"},{"issue":"April (6317)","key":"10.1016\/j.vaccine.2011.07.059_bib0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/350423a0","article-title":"A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene","volume":"350","author":"Kitamura","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0120","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2011.07.059_bib0125","doi-asserted-by":"crossref","first-page":"e5938","DOI":"10.1371\/journal.pone.0005938","article-title":"Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague","volume":"4","author":"Zauberman","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0130","doi-asserted-by":"crossref","first-page":"11490","DOI":"10.1073\/pnas.92.25.11490","article-title":"Studies of group B streptococcal infection in mice deficient in complement C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity","volume":"92","author":"Wessels","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2011.07.059_bib0135","first-page":"107","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0140","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00281-004-0184-0","article-title":"Innate-like B cells","volume":"26","author":"Kearney","year":"2005","journal-title":"Springer Semin Immunopathol"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2011.07.059_bib0150","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1073\/pnas.0813411106","article-title":"Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge","volume":"106","author":"Cole","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2011.07.059_bib0155","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/iai.63.8.3021-3029.1995","article-title":"Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization","volume":"63","author":"Nakajima","year":"1995","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.059_bib0160","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1997.56.471","article-title":"Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis","volume":"56","author":"Anderson","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.07.059_bib0165","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis","volume":"71","author":"Hill","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0170","series-title":"The challenge of highly pathogenic microorganisms","first-page":"269","article-title":"Protection against plague afforded by treatment with polyclonal \u03b1LcrV and \u03b1F1 antibodies","author":"Levy","year":"2010"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.07.059_bib0175","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.01162-08","article-title":"Yersinia pestis IS1541 transposition provides for escape from plague immunity","volume":"77","author":"Cornelius","year":"2009","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.07.059_bib0180","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/IAI.01125-07","article-title":"Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein","volume":"76","author":"Bartra","year":"2008","journal-title":"Infect Immun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.07.059_bib0185","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/IAI.73.9.6127-6137.2005","article-title":"Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis","volume":"73","author":"Cowan","year":"2005","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.07.059_bib0190","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ajpath.2010.11.067","article-title":"Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague","volume":"178","author":"Eisele","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0195","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infect Immun"},{"issue":"January","key":"10.1016\/j.vaccine.2011.07.059_bib0200","article-title":"Involvement of CD8+T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge","author":"Wang","year":"2010","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.07.059_bib0205","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/IAI.71.10.5892-5899.2003","article-title":"The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis","volume":"71","author":"Pujol","year":"2003","journal-title":"Infect Immun"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.07.059_bib0210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/iai.45.3.649-654.1984","article-title":"Growth in mouse peritoneal macrophages of Yersinia pestis lacking established virulence determinants","volume":"45","author":"Straley","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.059_bib0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4049\/jimmunol.146.1.316","article-title":"The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium Pseudomonas aeruginosa","volume":"146","author":"Markham","year":"1991","journal-title":"J Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.07.059_bib0220","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1128\/iai.62.8.3129-3137.1994","article-title":"Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells","volume":"62","author":"Rhinheart-Jones","year":"1994","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:19:59Z","timestamp":1759400399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11011042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":44,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0264410X11011042"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}